Dalde, Khasimira A.
HRN: 16-62-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/29/2023
02/04/2023
IV
1g
Q6
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes